Inhibitory effects of fumagillin and its analogue TNP-470 on the function, morphology and angiogenesis of an oestrogen-induced prolactinoma in Fischer 344 rats

Journal of Endocrinology

Volumn 150, Issue 1, 1996, Pages 99-106

  Stepien H ^a   Grochal, M ^a   Zielinski K W ^a   Mucha, S ^a   Kunert Radek, J ^a   Kulig, A ^a   Stawowy, A ^a   Pisarek, H ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLSTILBESTROL; ESTROGEN; FUMAGILLIN; FUMAGILLOL CHLOROACETYLCARBAMATE; PROLACTIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROLACTINOMA; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR GROWTH;

EID: 0030055716     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1500099     Document Type: Article

References (41)

1. Baird A, Esch F, Mormede P, Ueno M, Ling N, Bohlen P, Ying S-Y, Wahrenberg WB & Guillemin R 1986 Molecular characterisation of fibroblast growth factor: distribution and biological activities in various tissues. Recent Progress in Hormone Research 42 143-199.
2. Banerjee SK, De A & Sarkar DK 1994 Colocalization of prolactin and proliferating cell nuclear antigen in the anterior pituitary during estrogen-induced pituitary tumors. Cancer Letters 87 139-144.
3. Ben-Jonathan N 1985 Dopamine: a prolactin inhibiting hormone. Endocrine Reviews 6 564-589.
4. Blood CH & Zetter BR 1990 Tumor interactions with the vasculature: Angiogenesis and tumor metastasis. Biochimica et Biophysica Acta 1032 89-118.
5. Elias KA & Weiner RI 1984 Direct arterial vascularization of estrogen-induced prolactin secreting anterior pituitary tumors. Proceedings of the National Academy of Sciences of the USA 81 4549-4553.
6. Ferrara N, Schweigerer L, Neufeld G, Mitchell R & Gospodarowicz D 1987 Pituitary follicular cells produce basic fibroblast growth factor. Proceedings of the National Academy of Sciences of the USA 84 5773-5777.
7. Folkman J 1993 Diagnostic and therapeutic applications of angiogenesis research. Sciences de la Vie/Life Sciences 316 914-918.
8. Folkman J & Klagsbrun M 1987 Angiogenic factors. Science 235 442-447.
9. Folkman J, Langer R, Linhardt RJ, Haudenschild C & Taylor S 1983 Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. Science 221 719-725.
10. Gagliardi A & Collins DC 1993 Inhibition of angiogenesis by antiestrogens. Cancer Research 53 533-535.
11. Gagliardi A, Hadd H & Collins DC 1992 Inhibition of angiogenesis by suramin. Cancer Research 52 5073-5075.
12. Gratzner HG 1982 Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: a new reagent for detection of DNA replication. Science 218 474-475.
13. Halper J, Parnell PG, Carter BJ, Ren P & Scheithauer BW 1992 Presence of growth factors in human pituitary. Laboratory Investigation 66 639-645.
14. Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H & Folkman J 1990 Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348 555-557.
15. Inoue K, Sakai T & Hattori M 1991 The cell-adhesive effect of basic fibroblast factor on pituitary cells in vitro. Journal of Endocrinology 130 380-385.
16. Knighton DR & Figel VD 1991 Regulation of cutaneous wound healing by growth factors and the microenvironment. Investigative Radiology 26 604-611.
17. Larson GH, Koos RD, Sortino MA & Wise PM 1990 Acute effect of basic fibroblast growth factor on secretion of prolactin as assessed by the reverse hemolytic plaque assay. Endocrinology 126 927-934.
18. Lieberman ME, Maurer RA, Claude P & Gorski J 1982 Prolactin synthesis in primary cultures of pituitary cells: Regulation of estradiol. Molecular and Cellular Endocrinology 25 277-294.
19. Liotta LA, Steeg PS & Stetler-Stevenson WG 1991 Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64 327-336.
20. Lloyd RV 1983 Estrogen-induced hyperplasia and neoplasia in the rat anterior pituitary gland. An immunohistochemical study. American Journal of Pathology 113 198-206.
21. Lloyd HM, Meares JD & Jacobi J 1975 Effects of oestrogen and bromocriptine on in vivo secretion and mitosis in prolactin cells. Nature 255 497-498.
22. McNicol AM, Kubba MAG & McTeague E 1988 The mitogenic effect of corticotrophin-releasing factor on the anterior pituitary gland of the rat. Journal of Endocrinology 118 237-241.
23. Nabel EG, Yang Z, Plautz G, Forough R, Zhan X, Haudenschild CC, Maciag T & Nabel GJ 1993 Recombinant fibroblast growth factor-1 promotes intimai hyperplasia and angiogenesis in arteries in vivo. Nature 362 844-846.
24. Nakano H, Fawcet CP & McCann SM 1976 Enzymatic dissociation and short-term activation of isolated rat anterior pituitary cells for studies on the control of hormone secretion. Endocrinology 98 278-285.
25. Phelps C & Hymer WC 1983 Characterisation of oestrogen-induced adenohypophyseal tumors in the Fischer 344 rat. Neuroendocrinology 37 23-31.
26. Pisarek H & Stȩpień H 1992 The effect of mesulergine on prolactin secretion and anterior pituitary cells morphology in diethystilboestrol-treated female Wistar rats. Histology and Histopathology 7 111-117.
27. Poely RW, Fobes CD & Hall MJ 1964 Fuchsinophilia in early myocardial infarction. Archives of Pathology 77 325-329.
28. Sato Y & Rifkin DB 1988 Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis. Journal of Cell Biology 107 1199-1205.
29. Schlechter J, Ahmad N, Elias K & Weiner R 1987 Estrogen-induced tumors: Changes in the vasculature in two strains of rat. American Journal of Anatomy 179 315-323.
30. 3H]-thymidine incorporation by pituitary cells cultured in vitro. Endocrinology 109 1784-1786.
31. Stȩpień H, Wolaniuk A & Pawlikowski M 1978 Effect of pimozide and bromocriptine on anterior pituitary cell proliferation. Journal of Neural Transmission 42 239-242.
32. Stȩpień H, Żerek-Mełeń G, Mucha S, Winczyk K & Fryczak J 1994 Interleukin-1β stimulates cell proliferation in the intermediate lobe of the rat pituitary gland. Journal of Endocrinology 140 337-341.
33. Sternberger LA, Hardy PH, Cuculis JJ & Meyer GH 1979 The unlabelled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in the identification of Spirochetes. Journal of Histochemistry and Cytochemistry 18 315-333.
34. Takamiya Y, Friedlander MR, Brem H, Malick A & Martuza RL 1993 Inhibition of angiogenesis and growth of human nerve-sheath tumors by AGM-1470. Journal of Neurosurgery 78 470-476.
35. Tamargo RJ, Bok RA & Brem H 1991 Angiogenesis inhibition by minocycline. Cancer Research 51 672-675.
36. Taylor S & Folkman J 1982 Protamine is an inhibitor of angiogenesis. Nature 297 307-312.
37. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S & Gasparini G 1992 Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. Journal of the National Cancer Institute 84 1875-1887.
38. Weidner N, Carroll PR, Flax J, Blumenfeld W & Folkman J 1993 Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. American Journal of Pathology 143 401-409.
39. Wesseling P, Van Der Laak JAWM, De Leeuw H, Ruiter DJ & Burger PC 1994 Quantitative immunohistological analysis of the microvasculature in untreated human glioblastoma multiform. Journal of Neurosurgery 81 902-909.
40. Wiklund J, Wertz N & Gorski J 1981 A comparison of estrogen effects on uterine and pituitary growth and prolactin synthesis in F344 and Holtzman rats. Endocrinology 109 1700-1707.
41. Yamaoka M, Yamamoto T, Masaki T, Ikeyama S, Sudo K & Fujita T 1993 Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor 0-(chloroacetyl-carbamoyl)fumagillol (TNP-470; AGM-1470). Cancer Research 53 4262-4267.